Wall Street Zen cut shares of AirSculpt Technologies (NASDAQ:AIRS – Free Report) from a buy rating to a hold rating in a report published on Saturday morning.
AIRS has been the topic of a number of other reports. Leerink Partners set a $4.50 price target on AirSculpt Technologies in a research report on Thursday, May 14th. Weiss Ratings upgraded AirSculpt Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, July 1st. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average target price of $4.50.
Read Our Latest Analysis on AIRS
AirSculpt Technologies Price Performance
AirSculpt Technologies (NASDAQ:AIRS – Get Free Report) last issued its earnings results on Monday, August 10th. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.01). AirSculpt Technologies had a negative return on equity of 5.83% and a negative net margin of 7.79%.The business had revenue of $42.90 million during the quarter, compared to the consensus estimate of $44.14 million.
Institutional Investors Weigh In On AirSculpt Technologies
A number of hedge funds have recently made changes to their positions in the business. GSA Capital Partners LLP acquired a new stake in AirSculpt Technologies in the 2nd quarter valued at approximately $1,913,000. Flputnam Investment Management Co. bought a new position in shares of AirSculpt Technologies in the second quarter worth $3,114,000. Hsbc Holdings PLC acquired a new position in shares of AirSculpt Technologies during the first quarter valued at $135,000. Citizens Financial Group Inc. RI raised its stake in shares of AirSculpt Technologies by 11.3% during the first quarter. Citizens Financial Group Inc. RI now owns 265,861 shares of the company’s stock valued at $752,000 after purchasing an additional 26,961 shares in the last quarter. Finally, Royal Bank of Canada grew its position in AirSculpt Technologies by 259.6% in the 1st quarter. Royal Bank of Canada now owns 9,879 shares of the company’s stock valued at $28,000 after buying an additional 7,132 shares in the last quarter. Institutional investors own 91.54% of the company’s stock.
AirSculpt Technologies Company Profile
AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.
Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.
Read More
- Five stocks we like better than AirSculpt Technologies
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for AirSculpt Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AirSculpt Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
